Insider Trading: Nektar Therapeutics (NKTR.O)

NKTR.O on Nasdaq

10.98USD
25 Jul 2014
Price Change (% chg)

$-0.03 (-0.27%)
Prev Close
$11.01
Open
$10.93
Day's High
$11.05
Day's Low
$10.81
Volume
798,331
Avg. Vol
1,124,257
52-wk High
$15.34
52-wk Low
$8.87

Search Stocks
KRIVULKA JOSEPH J

Institutional Holders

% Shares Owned: 91.50%
# of Holders: 192
Total Shares Held: 116,187,565
3 Mo. Net Change: -273,678
# New Positions: 4
# Closed Positions: 2
# Increased Positions: 4
# Reduced Positions: 6
# Net Buyers: -2

Officers & Directors

Name Age Since Current Position

Robert Chess

57 2007 Independent Chairman of the Board

Howard Robin

61 2007 President, Chief Executive Officer, Director

John Nicholson

62 2007 Chief Financial Officer, Senior Vice President

Jillian Thomsen

48 2010 Senior Vice President - Finance, Chief Accounting Officer

Stephen Doberstein

55 2010 Senior Vice President, Chief Scientific Officer

Gil Labrucherie

41 2007 Senior Vice President, General Counsel, Secretary

Ivan Gergel

52 2014 Senior Vice President - Drug Development & Chief Medical Officer

Maninder Hora

60 Senior Vice President - Pharmaceutical Development and Manufacturing Operations

R. Scott Greer

55 2010 Independent Director

Joseph Krivulka

62 2005 Independent Director

Christopher Kuebler

60 2001 Independent Director

Lutz Lingnau

71 2007 Independent Director

Susan Wang

63 2003 Independent Director

Roy Whitfield

60 2000 Independent Director

Dennis Winger

66 2009 Independent Director

Jennifer Ruddock

Vice President - Investor Relations and Corporate Affairs
Search Stocks